Chronic myelogenous leukemia epidemiology and demographics

Revision as of 18:23, 12 June 2014 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search

Chronic myelogenous leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic myelogenous leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic myelogenous leukemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic myelogenous leukemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic myelogenous leukemia epidemiology and demographics

CDC on Chronic myelogenous leukemia epidemiology and demographics

Chronic myelogenous leukemia epidemiology and demographics in the news

Blogs on Chronic myelogenous leukemia epidemiology and demographics

Directions to Hospitals Treating Chronic myelogenous leukemia

Risk calculators and risk factors for Chronic myelogenous leukemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Chronic myelogenous leukemia (CML) occurs in all age groups, but most commonly in the middle-aged and elderly. CML affects slightly more men than women. CML represents about 15–20% of all cases of adult leukemia in Western populations.[1] In 2011, the age-adjusted incidence of CML was 1.81 per 100,000 persons in the United States.[2]

Epidemiology

Incidence

  • In 2011, the age-adjusted incidence of CML was 1.81 per 100,000 persons in the United States.[2]

Age

  • While the overall age-adjusted incidence of CML in the United States between 2007 and 2011 is 1.7 per 100,000, the age-adjusted incidence of CML by age category is:[2]
    • Under 65 years: 0.9 per 100,000
    • 65 and over: 6.8 per 100,000

Gender

  • In the United States, the age-adjusted incidence of CML by gender on 2011 is:[2]
    • In males: 2.42 per 100,000 persons
    • In females: 1.30 per 100,000 persons
  • Shown below is an image depicting the observed incidence of myeloid leukemia by gender in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[2]

Observed incidence of myeloid leukemia by gender in the United States between 1975 and 2011

References

  1. Faderl S, Talpaz M, Estrov Z, Kantarjian HM (1999). "Chronic myelogenous leukemia: biology and therapy". Annals of Internal Medicine. 131 (3): 207–219. PMID 10428738.
  2. 2.0 2.1 2.2 2.3 2.4 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.


Template:WikiDoc Sources